Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (11)

2024

  1. The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells

    Gut, Vol. 73, Núm. 9, pp. 1489-1508

2022

  1. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia

    Oral Oncology, Vol. 134

2020

  1. Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Premature aging and cancer development in transgenic mice lacking functional CYLD

    Aging, Vol. 11, Núm. 1, pp. 127-159

2017

  1. A transposon-based analysis reveals RASA1 is involved in triple-negative breast cancer

    Cancer Research, Vol. 77, Núm. 6, pp. 1357-1368

  2. IKKβ-mediated resistance to skin cancer development is Ink4a/Arf-dependent

    Molecular Cancer Research, Vol. 15, Núm. 9, pp. 1255-1264

2016

  1. IKKα regulates the stratification and differentiation of the epidermis: Implications for skin cancer development

    Oncotarget, Vol. 7, Núm. 47, pp. 76779-76792

  2. Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53

    Oncotarget, Vol. 7, Núm. 15, pp. 20902-20918

2014

  1. Molecular epidemiology and virulence of Escherichia coli O16: H5-ST131: Comparison with H30 and H30-Rx subclones of O25b: H4-ST131

    International Journal of Medical Microbiology, Vol. 304, Núm. 8, pp. 1247-1257

2011

  1. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 9, pp. 2011-2021

2009

  1. Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma

    Cancer Research, Vol. 69, Núm. 3, pp. 1099-1108